Markets

Meesho IPO Performance Analysis – December 2025

December 4, 2025

Meesho IPO Performance Analyzed Meesho’s Initial Public Offering (IPO) saw a huge surge in demand from investors. The IPO, which opened for bidding on December....

India Equity Indices Analysis: Nifty 50, Sensex & Growth Forecast

December 4, 2025

## India’s Equity Indices Analyzed Key Points * Indian stock indices showed modest gains, ending a four-day losing streak. * Investor sentiment remained cautious due....

Indian Rupee Performance Analysis – Trends & Factors

December 4, 2025

Indian Rupee Performance Analyzed The Indian rupee’s value changed significantly on Thursday, moving back up after hitting a low point. It gained 19 paise to....

Global Markets Analysis: Investor Sentiment Shifts

December 4, 2025

Global Markets Analyzed: Shifts in Investor Sentiment Global stock markets had a varied day on Thursday, showing investors are worried about several things. News that....

Subros Wins Major Indian Railways Contract

December 4, 2025

Subros’ Indian Railways Contracts Analyzed Subros, a company that makes air conditioning systems for trains, has won a big new deal with Indian Railways. This....

SJVN Ltd Stock Analysis: Price, Trends & Key Points

December 4, 2025

SJVN Ltd Stock Performance Analyzed SJVN Ltd’s stock price is currently at Rs 75.54, which represents a small decrease of 0.59% for the day, as....

RBI Bond Purchases: Analysis & Key Points

December 4, 2025

RBI’s Actions Analyzed: What You Need to Know The Reserve Bank of India (RBI) is planning to buy up a lot of government bonds –....

Lupin & Valorum Armlupeg Biosimilar Partnership

December 4, 2025

Lupin’s Armlupeg Biosimilar Partnership Analyzed Lupin, a major drug maker, has teamed up with Valorum Biologics, a U.S. company focused on making cheaper versions of....

Armlupeg Biosimilar Commercialization Deal with Valorum Biologics

December 4, 2025

Armlupeg Biosimilar Commercialization Analyzed Lupin, a drug maker, has teamed up with Valorum Biologics, a company that specializes in creating similar versions of medicines (biosimilars),....

B Group Stock Losses Analyzed – December 4, 2025

December 4, 2025

Stock Market Performance Analyzed: ‘B’ Group Losers Today, December 4th, 2025, several companies within the BSE’s ‘B’ group experienced significant drops in stock value. This....

Previous Next